Publications
- August 17, 2017
-
August 17, 2017
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability
LaRocca NG, Hudson LD, Rudick R, Amtmann D, Balcer L, Benedict R, Bermel R, Chang I, Chiaravalloti ND, Chin P, Cohen JA, Cutter GR, Davis MD, DeLuca J, Feys P, Francis G, Goldman MD, Hartley E, Kapoor R, Lublin F, Lundstrom G, Matthews PM, Mayo N, Meibach R, Miller DM, Motl RW, Mowry EM, Naismith R, Neville J, Panagoulias J, Panzara M, Phillips G, Robbins A, Sidovar MF, Smith KE, Sperling B, Uitdehaag BM, Weaver J. The MSOAC Approach to Developing Performance Outcomes to Measure and Monitor Multiple Sclerosis Disability. Multiple Sclerosis Journal. 2017 Aug 11;1352458517723718.
-
July 28, 2017
Dopamine transporter neuroimaging as an enrichment biomarker in early Parkinson’s disease clinical trials: a disease progression modeling analysis
Conrado DJ, Nicholas T, Tsai K, Macha S, Sinha V, Stone J, Corrigan B, Bani M, Muglia P, Watson IA, Kern VD, Sheveleva E, Marek K, Stephenson DT, Romero K, on behalf of the Critical Path for Parkinson’s (CPP) Parkinson’s Disease Modeling and Simulation Working Group. Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson’s Disease Clinical Trials: A Disease Progression Modeling Analysis: Dopamine Transporter Imaging Enrichment Biomarker. Clinical and Translational Science. 2017 Jul 27.
-
July 4, 2017
Open Innovation: Towards Sharing of Data, Models and Workflows
Conrado DJ, Karlsson MO, Romero K, Sarr C, Wilkins JJ. Open Innovation: Towards Sharing of Data, Models and Workflows. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences. 2017 Jul 4.
-
June 12, 2017
Regulatory Science in Neonates: A Framework That Supports Evidence-Based Drug Therapy
Turner MA, Portman RJ, Davis JM. Regulatory Science in Neonates: A Framework That Supports Evidence-Based Drug Therapy. JAMA pediatrics. 2017 Jun 12.